Learn | Resources to take control of your cancer

Common reasons for discontinuing endocrine therapy and CDK 4/6 inhibitorsIf you have HR+/HER2- metastatic breast...

What is genomic testing and how can it personalize cancer treatment? Breast cancer treatment is...

Managing breast cancer treatment side effects: CDK 4/6 inhibitorsWhen you have hormone receptor-positive, HER2-negative metastatic...

Dr. Sara Hurvitz, a medical oncologist and clinical research leader at Fred Hutch, recently joined...

For Triple Negative Breast Cancer (TNBC) Day, we’re revisiting our insightful “Ask the Expert” session...

Knowing your ESR1 status provides your care team with invaluable insights that can help optimize...

During Black History Month, we’re emphasizing the importance of diversity in clinical trials to help...

Navigating sexuality and intimacy after a breast cancer diagnosis can be challenging. We spoke with...

Keep reading for Raluca’s full story. The following questions and responses have been lightly edited for...

In our webinar titled “Unlocking Precision Care: Genomic Testing for Breast Cancer Management,” medical oncologist...

In the U.S., breast cancer is the most common cancer in women (other than skin...

As we close out 2024, we’re taking this opportunity to recognize and acknowledge how far...